| Metric | FY 2025↕ | FY 2024↕ | FY 2023↕ | FY 2022↕ | FY 2021↕ | FY 2020↕ | FY 2019↕ | FY 2018↕ |
|---|---|---|---|---|---|---|---|---|
| Revenue | $17.2B | $18.9B | $3.8B | $19.5B | $22.1B | $5.9B | $5.6B | $5.1B |
| Cost of Revenue | — | — | — | — | — | — | — | — |
| Gross Profit | — | — | — | — | — | — | — | — |
| R&D Expense | — | — | — | — | — | — | — | — |
| SG&A Expense | $3.3B | $3.0B | $3.2B | $3.3B | $3.5B | $3.4B | $3.1B | $3.0B |
| Operating Income | — | — | — | $4.2B | $4.9B | $4.4B | $4.5B | $4.4B |
| Net Income | $3.6B | $5.4B | $4.7B | $4.2B | $4.3B | $4.8B | $3.3B | $2.9B |
| EPS (Basic) | $6.84 | $9.68 | $0.46 | $6.62 | $6.42 | $1.36 | $1.07 | $0.69 |
| EPS (Diluted) | $6.82 | $9.63 | $0.46 | $6.59 | $6.39 | $1.35 | $1.06 | $0.69 |
| Metric | FY 2025↕ | FY 2024↕ | FY 2023↕ | FY 2022↕ | FY 2021↕ | FY 2020↕ | FY 2019↕ | FY 2018↕ |
|---|---|---|---|---|---|---|---|---|
| Total Assets | $116.5B | $117.6B | $126.7B | $131.0B | $157.5B | $165.1B | $152.8B | $140.4B |
| Current Assets | — | — | — | — | — | — | — | — |
| Cash & Equivalents | $6.2B | $6.2B | $4.3B | $3.9B | $5.1B | $5.1B | $4.9B | $4.3B |
| Total Liabilities | $87.0B | $91.5B | $104.7B | $108.7B | $124.3B | $131.5B | $123.8B | $116.9B |
| Current Liabilities | — | — | — | — | — | — | — | — |
| Stockholders' Equity | $29.5B | $26.1B | $22.0B | $22.4B | $33.3B | $33.6B | $29.0B | $23.5B |
| Metric | FY 2025↕ | FY 2024↕ | FY 2023↕ | FY 2022↕ | FY 2021↕ | FY 2020↕ | FY 2019↕ | FY 2018↕ |
|---|---|---|---|---|---|---|---|---|
| Operating Cash Flow | $2.6B | $2.7B | $3.2B | $3.9B | $5.1B | $6.0B | $5.5B | $6.0B |
| Investing Cash Flow | $1.6B | $2.8B | $0.8B | $-1.5B | $-2.4B | $-4.6B | $-3.2B | $-3.6B |
| Capital Expenditures | — | — | — | — | — | — | — | — |
| Financing Cash Flow | $-4.1B | $-3.5B | $-3.7B | $-3.6B | $-2.7B | $-1.1B | $-1.7B | $-1.6B |